[Therapeutic and preventive values of phenobarbital in the prevention and treatment of neonatal jaundice].
D000017:ABO Blood-Group System; D000284:Administration, Oral; D001663:Bilirubin / Q000097:blood; D001724:Birth Weight; D001787:Blood Group Incompatibility / Q000188:drug therapy / Q000517:prevention & control; D005260:Female; D005865:Gestational Age; D006801:Humans; D007231:Infant, Newborn; D007234:Infant, Premature; D007235:Infant, Premature, Diseases / Q000188:drug therapy / Q000517:prevention & control*; D007273:Injections, Intramuscular; D007567:Jaundice, Neonatal / Q000188:drug therapy / Q000517:prevention & control*; D010634:Phenobarbital / Q000008:administration & dosage / Q000627:therapeutic use*; D011247:Pregnancy; D012204:Rh-Hr Blood-Group System
D000017:ABO Blood-Group System; D012204:Rh-Hr Blood-Group System; D001663:Bilirubin; D010634:Phenobarbital
Der therapeutische und prophylaktische Wert des Phenobarbitals in der Praevention und Behandlung von Icterus gravis neonatorum.